{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:42:07Z","timestamp":1794624127621,"version":"4.9.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Central nervous system overlapping autoimmune syndromes are uncommon, especially with the coexistence of MOG-IgG and GFAP-IgG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 23-year-old woman presented with transient convulsions, a loss of consciousness, persistent fever, headache, and vomiting. Cerebrospinal fluid (CSF) analysis revealed elevated cellularity, and magnetic resonance imaging (MRI) showed diffuse leptomeningeal enhancement. She had fever and headache with antiviral and antibiotic treatment for 2 weeks, and she had empirical anti-tuberculosis treatment and oral prednisolone therapy. She was followed for 3 months after presentation with improved symptoms and normal CSF analysis. A 3-month follow-up MRI showed asymmetric lesions in the cerebellum, corona radiata, and white matter with enhancement. The anti-tuberculosis treatment was continued, and steroid therapy was discontinued. After she stopped taking prednisolone, an interrupted headache gradually appeared. MRI at 4 months after presentation revealed a partial reduction in lesions but enlarged areas in the left cerebellum and right parietal white matter and a new lesion in the region of the right ependyma with linear enhancement. Her CSF was positive for anti-myelin oligodendrocyte glycoprotein (MOG) and anti-glial fibrillary acidic protein (GFAP) antibodies using a transfected cell-based assay. She was diagnosed with overlapping syndrome of MOG\u2011IgG\u2011associated disease and GFAP astrocytopathy. She received steroid pulse therapy (methylprednisolone, 1\u00a0g for 5 days), followed by a gradual tapering of oral prednisolone and the addition of an immunosuppressant (tacrolimus, 3\u00a0mg per day). Six months after the initial presentation, she had no symptoms. An MRI showed that the lesions had diminished, and no enhancement was found.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We report a case that was positive for double antibodies, which was initially misdiagnosed as infectious meningoencephalitis. This case broadens the clinical and phenotypic presentation of the overlapping syndrome spectrum.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-021-02381-8","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T03:02:57Z","timestamp":1631242977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Overlapping syndrome mimicking infectious meningoencephalitis in a patient with MOG and GFAP IgG"],"prefix":"10.1186","volume":"21","author":[{"given":"Suqiong","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuajin","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bitao","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,10]]},"reference":[{"issue":"11","key":"2381_CR1","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","volume":"73","author":"B Fang","year":"2016","unstructured":"Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol. 2016;73(11):1297\u2013307.","journal-title":"JAMA Neurol"},{"key":"2381_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fneur.2018.00251","volume":"9","author":"X Yang","year":"2018","unstructured":"Yang X, Xu H, Ding M, Huang Q, Chen B, Yang H, et al. Overlapping autoimmune syndromes in patients with glial fibrillary acidic protein antibodies. Front Neurol. 2018;9:251.","journal-title":"Front Neurol"},{"key":"2381_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.msard.2018.12.036","volume":"28","author":"T Liu","year":"2019","unstructured":"Liu T, Chen B, Yang H, Huang J, Liu S, Yang X, et al. Screening for autoantibodies in inflammatory neurological syndrome using fluorescence pattern in a tissue-based assay: cerebrospinal fluid findings from 793 patients. Mult Scler Relat Disord. 2019;28:177\u201383.","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"2381_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/ene.13531","volume":"25","author":"Y Long","year":"2018","unstructured":"Long Y, Liang J, Xu H, Huang Q, Yang J, Gao C, et al. Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study. Eur J Neurol. 2018;25(3):477\u201383.","journal-title":"Eur J Neurol"},{"issue":"2","key":"2381_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","volume":"81","author":"EP Flanagan","year":"2017","unstructured":"Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients. Ann Neurol. 2017;81(2):298\u2013309.","journal-title":"Ann Neurol"},{"issue":"10","key":"2381_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/jnnp-2017-315998","volume":"88","author":"JW Hyun","year":"2017","unstructured":"Hyun JW, Woodhall MR, Kim SH, Jeong IH, Kong B, Kim G, et al. Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases. J Neurol Neurosurg Psychiatry. 2017;88(10):811\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"2381_CR7","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1007\/s00415-020-09869-2","volume":"267","author":"J Ding","year":"2020","unstructured":"Ding J, Ren K, Wu J, Li H, Sun T, Yan Y, et al. Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy. J Neurol. 2020;267(9):2589\u201393.","journal-title":"J Neurol"},{"issue":"7","key":"2381_CR8","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.4049\/jimmunol.1302911","volume":"192","author":"K Sasaki","year":"2014","unstructured":"Sasaki K, Bean A, Shah S, Schutten E, Huseby PG, Peters B, et al. Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells. J Immunol. 2014;192(7):3029\u201342.","journal-title":"J Immunol"},{"key":"2381_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.msard.2018.02.020","volume":"21","author":"J Li","year":"2018","unstructured":"Li J, Xu Y, Ren H, Zhu Y, Peng B, Cui L. Autoimmune GFAP astrocytopathy after viral encephalitis: a case report. Mult Scler Relat Disord. 2018;21:84\u20137.","journal-title":"Mult Scler Relat Disord"},{"issue":"7374","key":"2381_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature10554","volume":"479","author":"K Berer","year":"2011","unstructured":"Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479(7374):538\u201341.","journal-title":"Nature"},{"issue":"6","key":"2381_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1212\/NXI.0000000000000625","volume":"6","author":"S Winklmeier","year":"2019","unstructured":"Winklmeier S, Schluter M, Spadaro M, Thaler FS, Vural A, Gerhards R, et al. Identification of circulating MOG-specific B cells in patients with MOG antibodies. Neurol Neuroimmunol Neuroinflamm. 2019;6(6):625.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"2381_CR12","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/jnnp-2018-318231","volume":"89","author":"A Uzawa","year":"2018","unstructured":"Uzawa A, Mori M, Kuwabara S. MOG antibody disorders and AQP4 antibody NMO spectrum disorders share a common immunopathogenesis. J Neurol Neurosurg Psychiatry. 2018;89(9):900.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2381_CR13","doi-asserted-by":"publisher","first-page":"576999","DOI":"10.1016\/j.jneuroim.2019.576999","volume":"334","author":"A Kimura","year":"2019","unstructured":"Kimura A, Takemura M, Yamamoto Y, Hayashi Y, Saito K, Shimohata T. Cytokines and biological markers in autoimmune GFAP astrocytopathy: the potential role for pathogenesis and therapeutic implications. J Neuroimmunol. 2019;334:576999.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"2381_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/ijms17030273","volume":"17","author":"MJ Zatonska","year":"2016","unstructured":"Zatonska MJ, Lyszczarz AK, Michalak S, Kozubski W. The Immunology of neuromyelitis optica-current knowledge, clinical implications, controversies and future perspectives. Int J Mol Sci. 2016;17(3):273.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2381_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","volume":"89","author":"S Ramanathan","year":"2018","unstructured":"Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC, et al. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 2018;89(2):127\u201337.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"2381_CR16","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140(12):3128\u201338.","journal-title":"Brain"},{"issue":"11","key":"2381_CR17","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1177\/1352458519837705","volume":"25","author":"S Salama","year":"2019","unstructured":"Salama S, Khan M, Pardo S, Izbudak I, Levy M. MOG antibody-associated encephalomyelitis\/encephalitis. Mult Scler. 2019;25(11):1427\u201333.","journal-title":"Mult Scler"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02381-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-021-02381-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02381-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T03:03:04Z","timestamp":1631242984000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02381-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2381"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02381-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-58053\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-58053\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,10]]},"assertion":[{"value":"2 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained by the ethical committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"348"}}